Selective Laser Trabeculoplasty is clinically proven to treat glaucoma by safely and effectively reducing intraocular pressure in a single, office procedure. SLT can be an effective adjunct to medication therapy or used as a primary treatment to reduce or eliminate the need for topical glaucoma medications, along with their common systemic side effects. SLT has the potential to save your patients thousands of dollars in prescription medication costs and improve compliance.

Selective Laser Trabeculoplasty (SLT) improves the flow of fluid in the eye, which in turn lowers patient’s eye pressure. It is an advancement over other lasers (e.g. ALT) that have been used safely and effectively for open angle claucoma for two decades.